Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia
Clinical narrative: shortness of breath; chest pain; heart palpitations; body pain; fever everyday since; headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain) and PYREXIA (fever everyday since) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO Medical History Information was reported.  Concomitant products included METOPROLOL, METAMIZOLE, HYDROCHLOROTHIAZIDE, METFORMIN, VITAMIN D [VITAMIN D NOS], FISH OIL and ONE A DAY WOMEN'S for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain), PYREXIA (fever everyday since) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain), PYREXIA (fever everyday since) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Electrocardiogram: abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to urgent care for the reported events.  Patient received treatment including antihistamines. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain) and PYREXIA (fever everyday since) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO Medical History Information was reported.  Concomitant products included METOPROLOL, METAMIZOLE, HYDROCHLOROTHIAZIDE, METFORMIN, VITAMIN D [VITAMIN D NOS], FISH OIL and ONE A DAY WOMEN'S for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain), PYREXIA (fever everyday since) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), PAIN (body pain), PYREXIA (fever everyday since) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Electrocardiogram: abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to urgent care for the reported events.  Patient received treatment including antihistamines.